Biocon signs licensing and supply pact with Biomm S.A for Semaglutide commercialisation in Brazil Read more
Novo Nordisk Wegovy’s NHS access marks milestone in obesity treatment, but challenges remain: GlobalData Read more
With oral Semaglutide, HCPs can provide robust HbA1c control to their type-II diabetes patients Read more